Company Filing History:
Years Active: 2001-2006
Title: Marion Mahnke: Innovator in Cytostatics
Introduction
Marion Mahnke is a distinguished inventor based in Steinen, Germany. She has made significant contributions to the field of cytostatics, particularly through her innovative processes and formulations. With a total of 3 patents, her work has had a notable impact on medical research and pharmaceutical development.
Latest Patents
Mahnke's latest patents focus on a fermentative preparation process for and crystal forms of cytostatics. The inventions relate to a new process for concentrating epothilones in culture media, a new method for the production of epothilones, and a new process for separating epothilones A and B. Additionally, she has developed a new strain obtained by mutagenesis for the production of epothilones, along with new crystal forms of epothilone B.
Career Highlights
Marion Mahnke is currently associated with Novartis AG, where she continues to advance her research in the pharmaceutical industry. Her innovative approaches have positioned her as a key figure in the development of effective cancer treatments.
Collaborations
Throughout her career, Mahnke has collaborated with notable colleagues, including Hans Hofmann and Klaus Memmert. These partnerships have further enhanced her research and contributed to the success of her inventions.
Conclusion
Marion Mahnke's contributions to the field of cytostatics exemplify her dedication to innovation and research. Her patents and collaborations reflect her commitment to advancing medical science and improving treatment options for patients.